cisplatin,fluorouracil,sintilimab,paclitaxel
eli lilly,innovent biologics
['sintilimab', 'orient-15', 'orien', 'esophageal', 'innovent']
innovent releases final analysis results of orient-15: the phase 3 study of sintilimab plus chemotherapy for the first-line treatment of esophageal squamous cell carcinoma at the aacr annual meeting 2023 
To develop and commercialize high-quality biopharmaceuticals that are affordable to ordinary people.